Phase-I prime-boost AIDS vaccine trial shows modest immune response

Published in The Hindu on September 12, 2011 The final results of the Phase I prime-boost AIDS (Acquired Immune Deficiency Syndrome) vaccine trial started in February 2009 and conducted at the two sites — Tuberculosis Research Centre (TRC), Chennai, and the National AIDS Research Institute (NARI), Pune — has shown that the vaccines are safe … Continue reading Phase-I prime-boost AIDS vaccine trial shows modest immune response

Dedicated lab for HIV vaccine design

Published in The Hindu on March 3, 2011 After conducting a couple of AIDS vaccine trials in India, the New York based International AIDS Vaccine Initiative (IAVI) is shifting its focus to research that will help in finding more efficacious vaccines. The Department of Biotechnology (DBT) along with IAVI will soon establish and operate a … Continue reading Dedicated lab for HIV vaccine design

AIDS vaccine trial: prime-boost elicits modest immune response

Published in The Hindu on September 30, 2010 The preliminary results of the Phase I prime-boost AIDS vaccine trial started in February 2009 and conducted at the Tuberculosis Research Centre (TRC), Chennai and the National AIDS Research Institute (NARI), Pune, has shown that the vaccine used is safe and its ability to elicit immune response … Continue reading AIDS vaccine trial: prime-boost elicits modest immune response

Editorial: Glimmer of hope

Published in The Hindu on October 3, 2009 After more than two decades of relentless effort and several failures, there is a glimmer of hope, from the results of the Phase III HIV/AIDS vaccine clinical trial conducted in Thailand. The vaccine candidates used in the prime-boost trial that started six years ago and involved more … Continue reading Editorial: Glimmer of hope

Swine flu: AIDS patients not at greater risk of infection

Published in The Hindu on August 13, 2009 The immune system of people with HIV/AIDS is compromised.Yet, they are not considered to be at a greater risk of getting infected with swine flu compared with the general population. "HIV infected people are not at a greater risk of getting infected with swine flu compared to … Continue reading Swine flu: AIDS patients not at greater risk of infection

Editorial: AIDS vaccine prospects brighten

Published in The Hindu on May 2, 2009 The recent enrolment of the first volunteer at the Tuberculosis Research Centre in Chennai for a Phase I prime-boost AIDS vaccine clinical trial to be conducted simultaneously at the centre and the National AIDS Research Institute in Pune marks a new beginning in the search for a … Continue reading Editorial: AIDS vaccine prospects brighten

Phase I prime-boost AIDS vaccine trial on

Published in The Hindu on April 19, 2009 The first volunteer for the Phase I prime-boost AIDS vaccine trial, which will have a duration of two years, has been enrolled by the Tuberculosis Research Centre (TRC) here. “The first volunteer was enrolled on April 1, 2009” said V.D. Ramanathan, Senior Deputy Director, TRC, who is … Continue reading Phase I prime-boost AIDS vaccine trial on

HPV vaccination: key factors studied

Published in The Hindu on September 11, 2008 A formative study was completed recently to understand the various facets of the society and health systems prior to introducing a vaccine that can prevent Human papillomavirus (HPV) infection that is responsible for causing cervical cancer in women. The results of the study were presented to the … Continue reading HPV vaccination: key factors studied

Editorial: A glimmer of hope

Published in The Hindu on August 23, 2008 The search for a safe and efficacious AIDS vaccine has received a shot in the arm. The Phase I trial, aimed primarily at ascertaining the safety and HIV–specific immune response of a candidate vaccine, has yielded encouraging results in the exercise conducted at the Tuberculosis Research Centre, … Continue reading Editorial: A glimmer of hope

Phase I prime-boost vaccine trial to be conducted in Chennai, Pune

Published in The Hindu on August 16, 2008 Next year may see the start of a Phase I prime-boost AIDS vaccine trial at the National AIDS Research Institute (NARI), Pune, and the Tuberculosis Research Centre (TRC), Chennai. The prime to be used will be ADVAX, a DNA-based vaccine, and the boost will be the MVA … Continue reading Phase I prime-boost vaccine trial to be conducted in Chennai, Pune